GE
65
-6
GOOGL
54
-5
AVGO
30
-5
LLY
37
-7
A
39
-4
FRT
45
-3
XEL
67
2
MTCH
30
8
NOC
34
-6
AZO
55
-3
TAP
60
-4
TDC
73
2
KSS
46
4
HBI
56
-2
FSLR
47
7
EL
20
2
CNP
44
-6
SYK
71
-2
K
56
-4
OMC
68
4
GE
65
-6
GOOGL
54
-5
AVGO
30
-5
LLY
37
-7
A
39
-4
FRT
45
-3
XEL
67
2
MTCH
30
8
NOC
34
-6
AZO
55
-3
TAP
60
-4
TDC
73
2
KSS
46
4
HBI
56
-2
FSLR
47
7
EL
20
2
CNP
44
-6
SYK
71
-2
K
56
-4
OMC
68
4
Financhill
Back

Veracyte Vs. ProPhase Labs Industry Stock Comparison

Buy
80

VCYT
Veracyte

Last Price:
35.95
Seasonality Move:
7.34%
Sell
22

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
18.16%
Buy
80
Veracyte (VCYT) is a Buy

Is Veracyte a Buy, Sell or Hold?

  • The current Veracyte [VCYT] share price is $37.04. The Score for VCYT is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.75. The Score for PRPH is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCYT Stock Price Chart

What is Veracyte's stock price today?

  • The Veracyte share price today is $37.04
    The current trend is moderately bullish and VCYT is experiencing selling pressure, which indicates risk of future bearish movement.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

VCYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 56.82 Buy
Chaikin Money Flow: -746810 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.96 - 36.96) Buy
Bollinger Bands (100): (24.76 - 35.14) Buy

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 16.45 Sell
Chaikin Money Flow: -317470 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 2.58) Sell
Bollinger Bands (100): (1.95 - 3.31) Sell

VCYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.51 Sell
20-day SMA: 35.25 Buy
50-day SMA: 33.83 Buy
200-day SMA: 25.95 Buy
8-day EMA: 37.35 Sell
20-day EMA: 35.91 Buy
50-day EMA: 33.76 Buy
200-day EMA: 28.2 Buy

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.15 Sell
20-day SMA: 1.85 Sell
50-day SMA: 2.2 Sell
200-day SMA: 3.93 Sell
8-day EMA: 1.11 Sell
20-day EMA: 1.62 Sell
50-day EMA: 2.12 Sell
200-day EMA: 3.55 Sell

Veracyte Earnings Growth & VCYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.22 per share, and a decrease next year of $0.21 per share.

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Veracyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):